Blueprint Medicines logo

Blueprint Medicines

Blueprint Medicines is a biotechnology company that is working to improve human health.

5

Funding Rounds

$240.0m

Money raised

Overview

Blueprint Medicines is a biotechnology company that is working to improve human health.

Funding series

Funding Series Analysis

The company Blueprint Medicines has raised a total of $25m in funding over 5 rounds.

Key Insights:

  • Blueprint Medicines Series B round Funding Round 2014: $25m
  • Blueprint Medicines Venture round, December 2016: $125m
  • Blueprint Medicines Series C round, November 2014: $50m
  • Blueprint Medicines Series A round, April 2011: $40m
Blueprint Medicines logo
Blueprint Medicines Series B round Funding Round 2014 $25m
Blueprint Medicines logo
Blueprint Medicines Venture round, December 2016 $125m
Blueprint Medicines logo
Blueprint Medicines Series C round, November 2014 $50m
Blueprint Medicines logo
Blueprint Medicines Series A round, April 2011 $40m

Industries

Blueprint Medicines is active in the following industries:
  • Synthetic chemistry
  • Healthcare
  • Diagnosis
  • Biopharmaceutical
  • Technology
  • Biology
  • Biotechnology
  • Life science
  • Engineering
  • Biomedical engineering